Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 499 of 499 entries
View as:

R2 in the Treatment of Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03715309 Org: User:
Start: 11/01/18 End: 11/01/20 Due: 11/01/21

Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06577532 Org: User:
Start: 09/24/24 End: 08/31/27 Due: 08/31/28

Methotrexate or Thiotepa Combined With R-CHOP and Orelabrutinib in CNSL Patients

Phase: N/A Priority: Normal
NCT ID: NCT06901999 Org: User:
Start: 04/30/25 End: 11/30/28 Due: 11/30/29

Study on the Accessibility and Feasibility of Intelligent Applet for Health Intervention of Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05501990 Org: User:
Start: 07/01/23 End: 12/31/25 Due: 12/31/26

Chinese FMDs Registry

Phase: N/A Priority: Normal
NCT ID: NCT05201521 Org: User:
Start: 01/27/22 End: 01/27/24 Due: 01/27/25

Comparison of RF and crYoballoon ablatiOn Therapy of AF（CRYO-AF）

Phase: N/A Priority: Normal
NCT ID: NCT03044951 Org: User:
Start: 11/30/16 End: 12/31/20 Due: 12/31/21

The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06746194 Org: User:
Start: 12/03/24 End: 12/31/28 Due: 12/31/29

Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHL

Phase: N/A Priority: Normal
NCT ID: NCT06695013 Org: User:
Start: 11/20/24 End: 03/20/27 Due: 03/20/28

CR-CHOP+X in Previously Untreated DEL

Phase: N/A Priority: Normal
NCT ID: NCT06701357 Org: User:
Start: 12/10/24 End: 12/01/28 Due: 12/01/29

Flow Index: a New Method for Assessing Respiratory Drive in Critically Ill Patients Based on Electrical Impedance Tomography

Phase: N/A Priority: Normal
NCT ID: NCT06876792 Org: User:
Start: 09/01/23 End: 12/30/25 Due: 12/30/26

Spinal Cord Stimulation for Parkinsonism

Phase: N/A Priority: Normal
NCT ID: NCT05171205 Org: User:
Start: 05/01/21 End: 12/31/26 Due: 12/31/27

Effect of a Self-designed MET Exercise Intervention on Cancer-related Fatigue in Patients With Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05401045 Org: User:
Start: 01/20/23 End: 07/29/23 Due: 07/29/24

Study Evaluating the Safety and Efficacy of iR2 in Untreated and Unfit Elderly Patients With DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT03949062 Org: User:
Start: 03/13/19 End: 05/31/22 Due: 05/31/23

Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03959150 Org: User:
Start: 01/05/20 End: 06/30/23 Due: 06/30/24

A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of Pulmonary Infection

Phase: N/A Priority: Normal
NCT ID: NCT04544215 Org: User:
Start: 07/01/20 End: 03/01/25 Due: 03/01/26

the Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT04388982 Org: User:
Start: 07/01/20 End: 08/31/22 Due: 08/31/23

Long Term Prospective Study of Tai Chi Intervention to Prevent MCI From Conversion to Dementia

Phase: N/A Priority: Normal
NCT ID: NCT05310890 Org: User:
Start: 09/30/22 End: 09/30/26 Due: 09/30/27

Effect of Pulmonary Rehabilitation on Perioperative Outcomes in Smoker Patients With Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03010033 Org: User:
Start: 01/20/17 End: 12/31/22 Due: 12/31/23

Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases

Phase: N/A Priority: Normal
NCT ID: NCT05193162 Org: User:
Start: 02/01/19 End: 07/31/26 Due: 07/31/27

Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05923879 Org: User:
Start: 06/30/23 End: 06/30/25 Due: 06/30/26

Cardiometabolic evalUation REgistry of Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT06939985 Org: User:
Start: 01/01/15 End: 05/31/30 Due: 05/31/31

The Efficacy and Safety of Puerarin in Obesity Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06968208 Org: User:
Start: 08/01/25 End: 12/31/29 Due: 12/31/30

Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 3)

Phase: N/A Priority: Normal
NCT ID: NCT04932187 Org: User:
Start: 08/01/21 End: 07/01/25 Due: 07/01/26

Acupoint Application With Herbal Fumigation and Wash for Preventing Diarrhea-induced Perianal Infection in Allo-HSCT Patients

Phase: N/A Priority: Normal
NCT ID: NCT06912347 Org: User:
Start: 03/18/25 End: 03/30/26 Due: 03/30/27